ArticleTranslational lung cancer research2024
Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case report.
Shiting Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.